Primary prevention of sickle cell disease
Primary prevention of sickle cell disease using preimplantation genetic testing and in vitro fertilization is cost-effective
- For couples with sickle cell trait (SCT) who are at risk for having a child with sickle cell disease (SCD), cost is a barrier to using in vitro fertilization (IVF) with preimplantation genetic testing for monogenic diseases (PGT-M) and insurance coverage is not universal.
- The objective of this study was to evaluate the cost-effectiveness of IVF+PGT-M for couples who both carry SCT and wish to avoid SCD in a child compared to natural conception with the possible birth of a child with SCD, and the associated lifetime medical costs and lost income. A cost-effectiveness analysis was performed with a decision analytic model. Sensitivity analyses, including Monte Carlo Simulations, assessed the impact of changes in input parameters on the incremental cost-effectiveness ratio (ICER).
- Probabilities and cost estimates were derived from the published literature. Effectiveness was measured in life years (LY) gained. The ICER was calculated to determine the cost-effectiveness of the IVF+PGT-M intervention. Compared to natural conception, IVF+PGT-M had an effectiveness gain of 30 LY, an additional cost of $572,392.68 per individual conceived, and an ICER of $19,319 per LY gained.
- The ICER is lower than a conservative, preset willingness to pay (WTP) threshold of $50,000 per LY gained. Monte Carlo Simulations demonstrated that, in 91% of iterations, IVF+PGT-M was cost-effective at the WTP of $50,000. IVF+PGT-M is a cost-effective strategy to avoid conceiving a child with SCD and broader insurance coverage is warranted. This article is protected by copyright. All rights reserved.
Anti-TRAIL-R2 Antibody |
|||
| A00410-1 | BosterBio | 200ug | EUR 565.2 |
|
Description: Goat Polyclonal TRAIL-R2 Antibody. Validated in IF, WB and tested in Human, Mouse. |
|||
Anti-MonoMethylH3R2me1-(R2) antibody |
|||
| STJ24010 | St John's Laboratory | 100 µl | EUR 471.6 |
|
Description: Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H3 family. Transcripts from this gene lack polyA tails; instead, they contain a palindromic termination element. This gene is located separately from the other H3 genes that are in the histone gene cluster on chromosome 6p22-p21.3. |
|||
Anti-PKA R2 (6A9) |
|||
| YF-MA10721 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to PKA R2 |
|||
Anti-PKA R2 (3C7) |
|||
| YF-MA14876 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to PKA R2 |
|||
Rat Anti-Mouse IL-12 p75 Monoclonal antibody, clone R2-9A5 |
|||
| CABT-L4486-1mg | Creative Diagnostics | 1 mg | EUR 1076.4 |
Rat Anti-Mouse IL-12 p75 Monoclonal antibody, clone R2-9A5 |
|||
| CABT-L4486-5mg | Creative Diagnostics | 5 mg | EUR 2886 |
Anti-GABA(B) R2 Purified |
|||
| 11-551-C100 | ExBio | 0.1 mg | EUR 244.8 |
Anti-Phospho-GABAB R2 (Ser783) Antibody |
|||
| P03830 | BosterBio | 100ul | EUR 477.6 |
|
Description: Rabbit Polyclonal Phospho-GABAB R2 (Ser783) Antibody. Validated in IF, WB and tested in Mouse, Rat. |
|||
PKA R2 Antibody |
|||
| AF6724 | Affbiotech | 100ul | EUR 420 |
TNF- R2 Antibody |
|||
| ABF0364 | Lifescience Market | 100 ug | EUR 525.6 |
TNF- R2 Antibody |
|||
| ABF0365 | Lifescience Market | 100 ug | EUR 525.6 |
PKA R2 Antibody |
|||
| DF3091 | Affbiotech | 200ul | EUR 420 |
IFN -gamma R2 ELISA KIT|Human |
|||
| EF010951 | Lifescience Market | 96 Tests | EUR 826.8 |
Anti-GABAB Receptor (Ser783), R2-Subunit antibody |
|||
| STJ120094 | St John's Laboratory | 100 µl | EUR 631.2 |
Recombinant Human VEGF R2/KDR Protein |
|||
| RP00084 | Abclonal | 20 μg | EUR 242.4 |
anti- IL 1 alpha antibody |
|||
| FNab04208 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against IL 1 alpha |
|||
Anti-IL-1 RII antibody |
|||
| STJ16100664 | St John's Laboratory | 100 µg | EUR 890.4 |
Anti-IL-1 beta Antibody |
|||
| A00101-2 | BosterBio | 1mg | EUR 1478.4 |
|
Description: Rabbit Polyclonal IL-1 beta Antibody. Validated in IP, IHC, WB and tested in Human. |
|||
Anti-IL 1 alpha antibody |
|||
| PAab04208 | Lifescience Market | 100 ug | EUR 463.2 |
Anti-IL-1 beta antibody |
|||
| STJ73078 | St John's Laboratory | 100 µg | EUR 430.8 |
Anti-IL-1 Alpha Antibody |
|||
| A01144 | BosterBio | 1mg | EUR 1478.4 |
|
Description: Rabbit Polyclonal IL-1 Alpha Antibody. Validated in WB and tested in Human. |
|||
mAb rat anti-mouse/human IL-5 |
|||
| CT694 | U-CyTech | 0.5 mg | EUR 312 |
Anti-IL-4Rα (Dupilumab), Human IgG4 Antibody |
|||
| A2148-100 | Biovision | 100 µg | EUR 612 |
Anti-IL-1β (Canakinumab), Human IgG1 Antibody |
|||
| A2144-100 | Biovision | 100 µg | EUR 564 |
Anti-IL-23α (Guselkumab), Human IgG1 Antibody |
|||
| A2147-100 | Biovision | 100 µg | EUR 612 |
Anti-IL-12β (Ustekinumab), Human IgG1 Antibody |
|||
| A2137-100 | Biovision | 100 µg | EUR 612 |
Anti-IL-17α (Secukinumab), Human IgG1 Antibody |
|||
| A2154-100 | Biovision | 100 µg | EUR 612 |
Anti-IL-17Rα (Brodalumab), Human IgG2 Antibody |
|||
| A2155-100 | Biovision | 100 µg | EUR 612 |
Notoginsenoside R2 |
|||
| HY-N0909 | MedChemExpress | 10mg | EUR 555.6 |
Stipuleanoside R2 |
|||
| TBZ1475 | ChemNorm | unit | Ask for price |
Notoginsenoside R2 |
|||
| TN028181 | ChemNorm | 20mg | Ask for price |
Human CellExp? IL-1 beta / IL-1F2, Human recombinant |
|||
| P1019-10 | Biovision | each | EUR 314.4 |
Human CellExp? IL-1 beta / IL-1F2, Human recombinant |
|||
| P1019-25 | Biovision | each | EUR 548.4 |
Recombinant Human IL-1 Receptor Antagonist Protein/IL-1RA/IL-1F3 |
|||
| C033-10ug | Novoprotein | 10ug | EUR 108 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 50mM TrisHCl, 200mM NaCl, pH 7.5. |
|||
Recombinant Human IL-1 Receptor Antagonist Protein/IL-1RA/IL-1F3 |
|||
| C033-1mg | Novoprotein | 1mg | EUR 1131.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 50mM TrisHCl, 200mM NaCl, pH 7.5. |
|||
Recombinant Human IL-1 Receptor Antagonist Protein/IL-1RA/IL-1F3 |
|||
| C033-500ug | Novoprotein | 500ug | EUR 808.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 50mM TrisHCl, 200mM NaCl, pH 7.5. |
|||
Recombinant Human IL-1 Receptor Antagonist Protein/IL-1RA/IL-1F3 |
|||
| C033-50ug | Novoprotein | 50ug | EUR 181.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 50mM TrisHCl, 200mM NaCl, pH 7.5. |
|||
Human IL-1 R antagonist / IL-1RA ELISA kit |
|||
| LF-EK50645 | Abfrontier | 1×96T | EUR 777.6 |
Rabbit Anti-Rat GABAb-R2 (GBR2) Antiserum #2 |
|||
| GBR22-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Anti-IL-1F6 / IL-36 |
|||
| PAab04239 | Lifescience Market | 100 ug | EUR 494.4 |
Anti-citrulline-Histone H3-R2/R8/R17 antibody |
|||
| STJ11100254 | St John's Laboratory | 100 µl | EUR 471.6 |
Anti-Phospho-PKA R2 (S99) Rabbit Monoclonal Antibody |
|||
| P03911 | BosterBio | 100ug/vial | EUR 476.4 |
|
Description: Rabbit Monoclonal Phospho-PKA R2 (S99) Antibody. Validated in IP, IF, WB and tested in Human, Mouse, Rat. |
|||
GABA(B) R2 Antibody |
|||
| 48296-100ul | SAB | 100ul | EUR 399.6 |
GABA(B) R2 Antibody |
|||
| 48296-50ul | SAB | 50ul | EUR 286.8 |
IFN Gamma R2 antibody |
|||
| 70R-6702 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal IFN Gamma R2 antibody |
|||
TRAIL R2 Antibody (DR5) |
|||
| R30940 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: TNFRSF10B (Tumor necrosis factor receptor superfamily, member 10b) has many names, including DR5, CD262, KILLER, TRICK2, TRICKB, ZTNFR9, TRAILR2, TRICK2A, TRICK2B, TRAIL R2, KILLER/DR5. The protein encoded by this gene is a member of the TNF-receptor superfamily, and contains an intracellular death domain. This receptor can be activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL/APO-2L), and transduces apoptosis signal. Mice have a homologous gene, tnfrsf10b, that has been essential in the elucidation of the function of this gene in humans. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein. By analysis of radiation hybrid panels, Walczak et al.(1997) mapped the gene to chromosome 8p22-p21. Northern blot analysis indicated that TRAIL R2 was expressed as a 4.4-kb mRNA in all tissues tested, with the highest levels of expression in peripheral blood lymphocytes, spleen, and ovary. |
|||
TRAIL R2 Antibody (DR5) |
|||
| R32639 | NSJ Bioreagents | 100ug | EUR 356.15 |
|
Description: TNFRSF10B (Tumor necrosis factor receptor superfamily, member 10b) is a human gene. It is also known as DR5 (Death Receptor 5), CD262, KILLER, TRICK2, TRICKB, ZTNFR9, TRAILR2, TRICK2A, TRICK2B, TRAIL-R2, KILLER/DR5. The protein encoded by this gene is a member of the TNF-receptor superfamily, and contains an intracellular death domain. This receptor can be activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL/APO-2L), and transduces apoptosis signal. Mice have a homologous gene, tnfrsf10b that has been essential in the elucidation of the function of this gene in humans. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein.By analysis of radiation hybrid panels, this gene is mapped to chromosome 8p22-p21. Northern blot analysis indicated that TRAILR2 was expressed as a 4.4-kb mRNA in all tissues tested, with the highest levels of expression in peripheral blood lymphocytes, spleen, and ovary. |
|||
TRAIL R2 Antibody / DR5 |
|||
| RQ6120 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: TNFRSF10B (Tumor necrosis factor receptor superfamily, member 10b) is a human gene. It is also known as DR5, CD262, KILLER, TRICK2, TRICKB, ZTNFR9, TRAILR2, TRICK2A, TRICK2B, TRAIL-R2, KILLER/DR5. The protein encoded by this gene is a member of the TNF-receptor superfamily, and contains an intracellular death domain. This receptor can be activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL/APO-2L), and transduces apoptosis signal. Mice have a homologous gene, tnfrsf10b that has been essential in the elucidation of the function of this gene in humans. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein.By analysis of radiation hybrid panels, this gene is mapped to chromosome 8p22-p21. Northern blot analysis indicated that TRAILR2 was expressed as a 4.4-kb mRNA in all tissues tested, with the highest levels of expression in peripheral blood lymphocytes, spleen, and ovary. |
|||
TRAIL R2 Antibody / DR5 |
|||
| RQ4711 | NSJ Bioreagents | 100ul | EUR 356.15 |
|
Description: The protein encoded by the TNFRSF10B is a member of the TNF-receptor superfamily, and contains an intracellular death domain. Death receptor 5 can be activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF10/TRAIL/APO-2L), and transduces an apoptosis signal. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein. [RefSeq] |
|||
TRAIL R2 Antibody / DR5 |
|||
| V8186-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Tumor necrosis factor (TNF) is a pleiotropic cytokine whose function is mediated by two distinct cell surface receptors, designated TNF-R1 and TNF-R2, which are expressed on most cell types. TNF function is primarily mediated through TNF-R1 signaling. Both receptors belong to the growing TNF receptor superfamily which includes Fas antigen and CD40. TNF-R1 contains a cytoplasmic motif, termed the death domain, that has been found to be necessary for the transduction of the apoptotic signal. The death domain is also found in several other receptors, including Fas, DR2 (or TRUNDD), DR3 (death receptor 3), DR4 and DR5. TRUNDD, DR4 and DR5 are receptors for the apoptosis-inducing cytokine TRAIL. A non-death domain-containing receptor, designated decoy receptor (DcR1 or TRID), also specifically associates with TRAIL and may play a role in cellular resistance to apoptotic stimuli. |
|||
TRAIL R2 Antibody / DR5 |
|||
| V8186-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: Tumor necrosis factor (TNF) is a pleiotropic cytokine whose function is mediated by two distinct cell surface receptors, designated TNF-R1 and TNF-R2, which are expressed on most cell types. TNF function is primarily mediated through TNF-R1 signaling. Both receptors belong to the growing TNF receptor superfamily which includes Fas antigen and CD40. TNF-R1 contains a cytoplasmic motif, termed the death domain, that has been found to be necessary for the transduction of the apoptotic signal. The death domain is also found in several other receptors, including Fas, DR2 (or TRUNDD), DR3 (death receptor 3), DR4 and DR5. TRUNDD, DR4 and DR5 are receptors for the apoptosis-inducing cytokine TRAIL. A non-death domain-containing receptor, designated decoy receptor (DcR1 or TRID), also specifically associates with TRAIL and may play a role in cellular resistance to apoptotic stimuli. |
|||
TRAIL R2 Antibody / DR5 |
|||
| V8186SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: Tumor necrosis factor (TNF) is a pleiotropic cytokine whose function is mediated by two distinct cell surface receptors, designated TNF-R1 and TNF-R2, which are expressed on most cell types. TNF function is primarily mediated through TNF-R1 signaling. Both receptors belong to the growing TNF receptor superfamily which includes Fas antigen and CD40. TNF-R1 contains a cytoplasmic motif, termed the death domain, that has been found to be necessary for the transduction of the apoptotic signal. The death domain is also found in several other receptors, including Fas, DR2 (or TRUNDD), DR3 (death receptor 3), DR4 and DR5. TRUNDD, DR4 and DR5 are receptors for the apoptosis-inducing cytokine TRAIL. A non-death domain-containing receptor, designated decoy receptor (DcR1 or TRID), also specifically associates with TRAIL and may play a role in cellular resistance to apoptotic stimuli. |
|||
Recombinant human TRAIL-R2 (DR5)/Fc Chimera |
|||
| EXB0007 | ExBio | 0.05 mg | EUR 364.8 |
PKA-R2 beta Antibody |
|||
| AF6952 | Affbiotech | 100ul | EUR 420 |
PKA-R2 beta Antibody |
|||
| 20-abx012820 | Abbexa |
|
|
PKA-R2 beta Antibody |
|||
| DF7820 | Affbiotech | 200ul | EUR 420 |
Gingipain R2 (RGPB) Antibody |
|||
| 20-abx319597 | Abbexa |
|
|
IFN-?R2 Polyclonal Antibody |
|||
| ES4097-100ul | ELK Biotech | 100ul | EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against IFN-?R2 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
IFN-?R2 Polyclonal Antibody |
|||
| ES4097-50ul | ELK Biotech | 50ul | EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against IFN-?R2 from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
|||
Recombinant Human IFNAR2/IFN-alpha R2 Protein |
|||
| RP00386 | Abclonal | 10 μg | EUR 196.8 |
Human Interleukin-1 beta (IL-1 beta) Antibody |
|||
| 13132-05011 | AssayPro | 150 ug | EUR 260.4 |
TNF-R2 Polyclonal Antibody |
|||
| ABP52623-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of TNF-R2 from Human, Mouse, Rat. This TNF-R2 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human TNF-R2 at AA range: 350-430 |
|||
TNF-R2 Polyclonal Antibody |
|||
| ABP52623-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of TNF-R2 from Human, Mouse, Rat. This TNF-R2 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human TNF-R2 at AA range: 350-430 |
|||
TNF-R2 Polyclonal Antibody |
|||
| ABP52623-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of TNF-R2 from Human, Mouse, Rat. This TNF-R2 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human TNF-R2 at AA range: 350-430 |
|||
GABAB R2 Polyclonal Antibody |
|||
| ABP57064-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of GABAB R2 from Human, Mouse, Rat. This GABAB R2 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human GABAB R2 around the non-phosphorylation site of S893 |
|||
GABAB R2 Polyclonal Antibody |
|||
| ABP57064-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of GABAB R2 from Human, Mouse, Rat. This GABAB R2 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human GABAB R2 around the non-phosphorylation site of S893 |
|||
GABAB R2 Polyclonal Antibody |
|||
| ABP57064-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of GABAB R2 from Human, Mouse, Rat. This GABAB R2 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human GABAB R2 around the non-phosphorylation site of S893 |
|||
TNF-R2 Polyclonal Antibody |
|||
| ES3622-100ul | ELK Biotech | 100ul | EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against TNF-R2 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
TNF-R2 Polyclonal Antibody |
|||
| ES3622-50ul | ELK Biotech | 50ul | EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against TNF-R2 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA |
|||
GABAB R2 Polyclonal Antibody |
|||
| ES8063-100ul | ELK Biotech | 100ul | EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against GABAB R2 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
|||
GABAB R2 Polyclonal Antibody |
|||
| ES8063-50ul | ELK Biotech | 50ul | EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against GABAB R2 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
|||
Human CellExp? TRAIL R2 / TNFRSF10B, Mouse recombinant |
|||
| P1421-50 | Biovision | each | EUR 444 |
Anti-IL-2R alpha (Daclizumab), Human IgG1 Antibody |
|||
| A1099-200 | Biovision | each | EUR 874.8 |
Human Interleukin-1 alpha (IL-1 alpha) Antibody |
|||
| 32196-05111 | AssayPro | 150 ug | EUR 313.2 |
Anti-IL-6 receptor (Tocilizumab), Human IgG1 Antibody |
|||
| A1447-200 | Biovision | each | EUR 933.6 |
Anti-IL1R2/Il 1 Rii Antibody |
|||
| A03106-1 | BosterBio | 1 ml | EUR 476.4 |
|
Description: Rabbit Polyclonal IL1R2/Il 1 Rii Antibody. Validated in IP, WB and tested in Human. |
|||
Anti-IL-1 beta/IL1B Antibody |
|||
| A00101 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-IL-5 (Reslizumab), Humanized Antibody |
|||
| A2167-100 | Biovision | 100 µg | EUR 612 |
In vitro fertilisation with preimplantation genetictesting: the need for expanded insurance coverage
Technological advances in genetic testing have enabled prospective parents to learn about their risk of passing a genetic condition to their future children.
One option for those who want to ensure that their biological children do not inherit a genetic condition is to create embryos through in vitro fertilisation (IVF) and use a technique called preimplantation genetic testing (PGT) to screen embryos for genetic abnormalities before implantation.
Unfortunately, due to its high cost, IVF-with-PGT is out of reach for the vast majority of Americans. This article addresses an issue that has been underexplored in the medical ethics literature: the lack of insurance coverage for IVF-with-PGT.Within the US system, a key concept in insurance is that of medically necessary care, which broadly consists of diagnostic services and treatment services. In this article, I argue that IVF-with-PGT could be classified as either a diagnostic service or as a treatment service.
To make this case, I show that IVF-with-PGT is similar to other types of services that are often covered by US insurance providers. In light of these similarities, I argue that the current system is inconsistent with respect to what is-and is not-covered by insurance. To promote consistency and fairness in coverage, like cases should be treated alike-starting with greater coverage for IVF-with-PGT.
Lack of familiarity with genetictesting among patients in Ireland with Cancer
Background: Cancer gene panel testing is available in Ireland. The need for a clear strategy to deal with patient information generated from tumour genomic testing is recognised as a challenge in the National Cancer Strategy. However, the public’s attitude and opinions regarding these results is not known in Ireland.
Aims: This prospective questionnaire study assessed the knowledge and opinions of patients in a national oncology centre, surrounding cancer gene panel testing.
Methods: An anonymised modified validated questionnaire was completed by volunteering patients in the medical oncology department. It comprised 14 questions which assessed patient’s familiarity, intention, benefits and concerns associated with tumour genetic testing using a four-point Likert scale. Patients recorded their primary cancer diagnosis and family cancer history.
Results: Eighty-four patients completed the questionnaire with 77 (92%) patients declaring their primary cancer diagnosis. The median age was 56 (range 26 to 83) years. Overall, 42% (n = 35) of oncology patients were familiar/somewhat familiar with testing and 90% (n = 76) stated they would avail of genetic testing if available. Patients with breast cancer were no more likely to avail of genetic testing when compared with the non-breast cancer cohort (n = 21 vs. 56, p = 0.58) though they identified concerns with potential discrimination.
Conclusion: This is the first prospective Irish study to assess opinions surrounding cancer gene results. Addressing patient’s lack of information as regards genetic testing is the first step in establishing a national cancer genetics testing programme in Ireland.
Anti-IL-8 antibody |
|||
| STJ97720 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Mouse monoclonal to IL-8. |
|||
Anti-IL-8 antibody |
|||
| STJ98175 | St John's Laboratory | 100 µl | EUR 280.8 |
|
Description: Mouse monoclonal to IL-8. |
|||
anti-IL-8 (3E4D8) |
|||
| LF-MA30011 | Abfrontier | 100 ul | EUR 448.8 |
|
Description: Mouse Monoclonal to IL-8 |
|||
mAb mouse anti-human IL-8 |
|||
| CT264 | U-CyTech | 0.5 mg | EUR 312 |
IL-8/CXCL8, Human |
|||
| HY-P7224 | MedChemExpress | 50ug | EUR 596.4 |
Human IL-8 Protein |
|||
| abx060803-25ug | Abbexa | 25 ug | EUR 644.4 |
Human IL-8 Protein |
|||
| abx060804-25ug | Abbexa | 25 ug | EUR 644.4 |
Recombinant Human IL-8 |
|||
| P0180 | FN Test | 100ug | EUR 626.83 |
|
Description: Recombinant Human protein for IL-8 |
|||
Recombinant Human IL-8 |
|||
| SJB05-01 | Amyotop | 25µg/vial | EUR 342 |
Anti-IL-8 Monoclonal Antibody |
|||
| A00423-1 | BosterBio | 100ul | EUR 476.4 |
|
Description: Mouse Monoclonal Antibody for IL-8 Antibody (CXCL8) detection. Tested with IHC in Human, Mouse, Rat. |
|||
Human Interleukin-8 (IL-8) Antibody (Biotin Conjugate) |
|||
| 13102-05021 | AssayPro | 150 ug | EUR 313.2 |
Human IL-8 ELISA antibody pair |
|||
| CT748-10 | U-CyTech | 10-plate | EUR 656.4 |
Human IL-8 ELISA antibody pair |
|||
| CT748-20 | U-CyTech | 20-plate | EUR 1118.4 |
Human IL-8 Antibody (Biotin Conjugate) |
|||
| 33486-05121 | AssayPro | 150 ug | EUR 442.8 |
Human Interleukin 8 (IL-8) CLIA Kit |
|||
| abx195916-96tests | Abbexa | 96 tests | EUR 990 |
Human Interleukin 8,IL-8 ELISA KIT |
|||
| 201-12-0090 | SunredBio | 96 tests | EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human Interleukin 8, IL-8 ELISA KIT |
|||
| CSB-E04641h-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
|
Description: Quantitative sandwich ELISA kit for measuring Human Interleukin 8, IL-8 in samples from serum, cell culture supernates, saliva, urine, cerebrospinalfluid (CSF), tissue homogenates, cell lysates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human Interleukin 8, IL-8 ELISA KIT |
|||
| 1-CSB-E04641h | Cusabio |
|
|
|
Description: Quantitative sandwich ELISA kit for measuring Human Interleukin 8, IL-8 in samples from serum, cell culture supernates, saliva, urine, cerebrospinalfluid(CSF), tissue homogenates, cell lysates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Human Interleukin 8(IL-8)ELISA Kit |
|||
| GA-E0129HM-48T | GenAsia Biotech | 48T | EUR 346.8 |
Human Interleukin 8(IL-8)ELISA Kit |
|||
| GA-E0129HM-96T | GenAsia Biotech | 96T | EUR 559.2 |
Human IL-8(Interleukin 8) ELISA Kit |
|||
| EH0205 | FN Test | 96T | EUR 571.5 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 18.75pg/ml |
|||
Human Interleukin 8(IL-8)ELISA Kit |
|||
| QY-E04259 | Qayee Biotechnology | 96T | EUR 433.2 |
Human Interleukin 8,IL-8 ELISA KIT |
|||
| YLA1210HU-48T | Shanghai YL Biotech | 48T | EUR 435 |
Human Interleukin 8,IL-8 ELISA KIT |
|||
| YLA1210HU-96T | Shanghai YL Biotech | 96T | EUR 562.5 |
Human Interleukin-8 (IL-8) ELISA Kit |
|||
| LF-EK60006 | Abfrontier | 1×96T | EUR 948 |
human IL-8 His tag |
|||
| E410A07-100 | EnoGene | 100μg | EUR 1152 |
Human IL-8 ELISA kit |
|||
| CT212A | U-CyTech | 5-plate | EUR 554.4 |
Human IL-8 ELISA kit |
|||
| LF-EK50165 | Abfrontier | 1×96T | EUR 777.6 |
IL-8 ELISA KIT|Human |
|||
| EF003990 | Lifescience Market | 96 Tests | EUR 826.8 |
Human IL-8 ELISA Kit |
|||
| EHI0063 | Abclonal | 96Tests | EUR 625.2 |
IL-8/CXCL8, 72a.a., Human |
|||
| HY-P7380 | MedChemExpress | 50ug | EUR 596.4 |
IL-8 (Human) ELISA Kit |
|||
| K4169-100 | Biovision | each | EUR 874.8 |
Human Interleukin-8 (IL-8) AssayLite Antibody (RPE Conjugate) |
|||
| 13102-05051 | AssayPro | 150 ug | EUR 513.6 |
Human Interleukin-8 (IL-8) AssayLite Antibody (APC Conjugate) |
|||
| 13102-05061 | AssayPro | 150 ug | EUR 513.6 |
Human Interleukin-8 (IL-8) AssayLite Antibody (FITC Conjugate) |
|||
| 13102-05041 | AssayPro | 150 ug | EUR 513.6 |
Human Interleukin-8 (IL-8) AssayLite Antibody (PerCP Conjugate) |
|||
| 13102-05071 | AssayPro | 150 ug | EUR 565.2 |
rec Monocyte IL-8 (human) |
|||
| H-9625.0005 | Bachem | 5.0µg | EUR 194.4 |
|
Description: Sum Formula: C372H600N106O106S4; CAS# [142298-00-8] |
|||
rec Monocyte IL-8 (human) |
|||
| H-9625.0025 | Bachem | 25.0µg | EUR 457.2 |
|
Description: Sum Formula: C372H600N106O106S4; CAS# [142298-00-8] |
|||
rec Endothelial IL-8 (human) |
|||
| H-3742.0010 | Bachem | 10.0µg | EUR 340.8 |
|
Description: Sum Formula: C397H644N114O111S4; CAS# [142298-01-9] |
|||
rec Endothelial IL-8 (human) |
|||
| H-3742.0050 | Bachem | 50.0µg | EUR 1167.6 |
|
Description: Sum Formula: C397H644N114O111S4; CAS# [142298-01-9] |
|||
Recombinant Human IL-8 (72a.a.) |
|||
| HEILP-0801 | Cyagen | 5ug | Ask for price |
Recombinant Human IL-8 (77a.a.) |
|||
| HEILP-0802 | Cyagen | 5ug | Ask for price |
Recombinant Human IL-8 Protein |
|||
| RP00052 | Abclonal | 5 μg | EUR 178.8 |
Human IL-8 Recombinant Protein |
|||
| R00423-8 | BosterBio | 5ug/vial | EUR 310.8 |
|
Description: Interleukin-8 (IL-8), also known as CXCL8, is an ELR-positive CXC family member chemokine produced by macrophages and other cell types such as epithelial cells. ELR-positive CXC chemokines such as IL-8 specifically induce the migration of neutrophils, and interact with chemokine receptors CXCR1 and CXCR2. Human IL-8 Recombinant Protein is purified interleukin-8 produced in yeast. |
|||
Anti-bovine IL-8 (CXCL8) antibody |
|||
| STJ15100008 | St John's Laboratory | 250 µg | EUR 403.2 |
|
Description: These monoclonal antibodies enable sensitive and specific detection of bovine IL-8 in ELISpot. |
|||
Anti-bovine IL-8 (CXCL8) antibody |
|||
| STJ15100009 | St John's Laboratory | 250 µg | EUR 403.2 |
|
Description: This monoclonal antibody enables sensitive and specific detection of bovine IL-8 in ELISA. |
|||
CLIA kit for Human IL-8 (Interleukin 8) |
|||
| E-CL-H0048 | Elabscience Biotech | 1 plate of 96 wells | EUR 700.8 |
|
Description: A sandwich CLIA kit for quantitative measurement of Human IL-8 (Interleukin 8) in samples from Serum, Plasma, Cell supernatant |
|||
IL-8, CXCL8, Interleukin-8 (72 a.a.), human |
|||
| RC212-19A | Bio Basic | 5ug | EUR 125.26 |
IL-8, CXCL8, Interleukin-8 (77 a.a.), human |
|||
| RC212-19B | Bio Basic | 5ug | EUR 125.26 |
IL-8 Antibody |
|||
| BF0238 | Affbiotech | 200ul | EUR 540 |
IL-8 Antibody |
|||
| 5149-100 | Biovision | each | EUR 405.6 |
IL-8 Antibody |
|||
| F51235-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
|
Description: IL8 is a member of the CXC chemokine family. This chemokine is one of the major mediators of the inflammatory response. This chemokine is secreted by several cell types. It functions as a chemoattractant, and is also a potent angiogenic factor. |
|||
IL-8 Antibody |
|||
| F51235-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
|
Description: IL8 is a member of the CXC chemokine family. This chemokine is one of the major mediators of the inflammatory response. This chemokine is secreted by several cell types. It functions as a chemoattractant, and is also a potent angiogenic factor. |
|||
IL-8 Antibody |
|||
| R30420 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: Interleukin-8(IL-8) is a chemokine produced by macrophages and other cell types such as epithelial cells. It is also synthesized by endothelial cells, which store IL-8 in their storage vesicles, the Weibel-Palade bodies. In humans, the interleukin-8 protein is encoded by the IL8 gene. Interleukin-8(IL8) is a member of the CXC chemokine family(Hull et al., 2001). IL-8 is believed to play a role in the pathogenesis of bronchiolitis, a common respiratory tract disease caused by viral infection. This gene and other ten members of the CXC chemokine gene family form a chemokine gene cluster in a region mapped to chromosome 4q. The genes for IL8 have been co-localized on a 335-kb genomic fragment. |
|||
IL-8 Antibody |
|||
| R31932 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: Interleukin-8 (IL-8) is a chemokine produced by macrophages and other cell types such as epithelial cells. It is also synthesized by endothelial cells, which store IL-8 in their storage vesicles, the Weibel-Palade bodies. In humans, the interleukin-8 protein is encoded by the IL8 gene. Interleukin-8 (IL8) is a member of the CXC chemokine family. IL-8 is believed to play a role in the pathogenesis of bronchiolitis, a common respiratory tract disease caused by viral infection. This gene and other ten members of the CXC chemokine gene family form a chemokine gene cluster in a region mapped to chromosome 4q. The genes for IL8 have been co-localized on a 335-kb genomic fragment. |
|||
ELISA kit for Human IL-8 (Interleukin 8) |
|||
| E-EL-H0048 | Elabscience Biotech | 1 plate of 96 wells | EUR 452.4 |
|
Description: A sandwich ELISA kit for quantitative measurement of Human IL-8 (Interleukin 8) in samples from Serum, Plasma, Cell supernatant |
|||
ELISA kit for Human Interleukin 8,IL-8 |
|||
| EK0240 | SAB | 96 tests | EUR 723.6 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Interleukin 8,IL-8 in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Human Interleukin-8 (IL-8) AssayMax ELISA Kit |
|||
| EI1008-1 | AssayPro | 96 Well Plate | EUR 572.4 |
Human IL-8 AssayLite Antibody (RPE Conjugate) |
|||
| 33486-05151 | AssayPro | 150 ug | EUR 513.6 |
Human IL-8 AssayLite Antibody (APC Conjugate) |
|||
| 33486-05161 | AssayPro | 150 ug | EUR 513.6 |
Recombinant Human Interleukin-8/IL-8 (C-6His) |
|||
| CC97-10ug | Novoprotein | 10ug | EUR 175.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (C-6His) |
|||
| CC97-1mg | Novoprotein | 1mg | EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (C-6His) |
|||
| CC97-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (C-6His) |
|||
| CC97-50ug | Novoprotein | 50ug | EUR 406.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
Human IL-8 AssayLite Antibody (FITC Conjugate) |
|||
| 70021-05141 | AssayPro | 150 ug | EUR 513.6 |
Human IL-8 AssayLite Antibody (FITC Conjugate) |
|||
| 33486-05141 | AssayPro | 150 ug | EUR 513.6 |
Human IL-8 AssayLite Antibody (PerCP Conjugate) |
|||
| 33486-05171 | AssayPro | 150 ug | EUR 565.2 |
Recombinant Human Interleukin-8/IL-8 (Ser28-Ser99) |
|||
| C035-10ug | Novoprotein | 10ug | EUR 181.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ser28-Ser99) |
|||
| C035-1mg | Novoprotein | 1mg | EUR 2203.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ser28-Ser99) |
|||
| C035-500ug | Novoprotein | 500ug | EUR 1557.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ser28-Ser99) |
|||
| C035-50ug | Novoprotein | 50ug | EUR 424.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ala23-Ser99) |
|||
| C037-10ug | Novoprotein | 10ug | EUR 181.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ala23-Ser99) |
|||
| C037-1mg | Novoprotein | 1mg | EUR 2203.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ala23-Ser99) |
|||
| C037-500ug | Novoprotein | 500ug | EUR 1557.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human Interleukin-8/IL-8 (Ala23-Ser99) |
|||
| C037-50ug | Novoprotein | 50ug | EUR 412.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
IL-8 |
|||
| E5-00004 | EnoGene | 1mg | EUR 1152 |
ELISA kit for Human IL-8 |
|||
| KET6018-48T | Abbkine | 48T | EUR 242.4 |
|
Description: Quantitative sandwich ELISA for measuring Human IL-8 in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human IL-8 |
|||
| KET6018-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 1292.4 |
|
Description: Quantitative sandwich ELISA for measuring Human IL-8 in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human IL-8 |
|||
| KET6018-96T | Abbkine | 96T | EUR 346.8 |
|
Description: Quantitative sandwich ELISA for measuring Human IL-8 in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
Human IL-8 ELISA kit (4X96T) |
|||
| LF-EK50166 | Abfrontier | 4×96T | EUR 2641.2 |
Human IL-8/CXCL8 ELISA Kit |
|||
| RK00011 | Abclonal | 96 Tests | EUR 625.2 |
IL-8 (77 a.a.), human recombinant |
|||
| 4149-1000 | Biovision | each | EUR 4758 |
IL-8 (77 a.a.), human recombinant |
|||
| 4149-25 | Biovision | each | EUR 339.6 |
IL-8 (72 a.a.), human recombinant |
|||
| 4149M-1000 | Biovision | each | EUR 4758 |
IL-8 (72 a.a.), human recombinant |
|||
| 4149M-25 | Biovision | each | EUR 339.6 |
CymaxTM Human IL-8 ELISA Kit |
|||
| LF-EK0262 | Abfrontier | 1×96T | EUR 477.6 |
IL-8 (77 a.a.), human recombinant |
|||
| P1026-.025 | ApexBio | 25 µg | EUR 360 |
|
Description: Interleukin-8 (IL-8) is a proinflammatory CXC chemokine produced by macrophages, epithelial cells. IL-8 is also synthesized by endothelial cells, which store IL-8 in their storage vesicles, the Weibel-Palade bodies |
|||
IL-8 (77 a.a.), human recombinant |
|||
| P1026-1 | ApexBio | 1 mg | EUR 5071.2 |
|
Description: Interleukin-8 (IL-8) is a proinflammatory CXC chemokine produced by macrophages, epithelial cells. IL-8 is also synthesized by endothelial cells, which store IL-8 in their storage vesicles, the Weibel-Palade bodies |
|||
Human IL-8 PicoKine ELISA Kit |
|||
| EK0413 | BosterBio | 96 wells | EUR 510 |
|
Description: For quantitative detection of human IL-8 in cell culture supernates, serum and plasma(heparin, EDTA, citrate). |
|||
IL-8 ELISA Kit (Human) (OKBB00192) |
|||
| OKBB00192 | Aviva Systems Biology | 96 Tests | EUR 606 |
|
Description: Description of target: Interleukin-8, also called neutrophil-activating peptide-1 or SCYB8, is a tissue-derived peptide secreted by several types of cells in response to inflammatory stimuli. Monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8, suggested gene symbol IL8) is a cytokine that chemoattracts and activates neutrophils.1 IL-8 is produced and released from human adipose tissue and from isolated adipocytes in vitro, which may indicate that IL-8 from adipose tissue could be involved in some of the obesity-related complications.2 The MDNCF/IL-8 gene is placed on the human gene map at position 4q12-q21. This is the same location where at least three other members (platelet factor 4, melanoma growth stimulatory activity, and interferon-gamma induced factor) of the platelet factor 4 gene superfamily reside.1 Human IL-8 consists of 99 amino acids in precursor form and 79 amino acids in mature form.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 1 pg/ml |
|||
IL-8/CXCL8 (CHO-expressed), Human |
|||
| HY-P7379 | MedChemExpress | 50ug | EUR 596.4 |
Genorise® Recombinant human IL-8 |
|||
| GR104177 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Biotinylated Anti-Human IL-8 Polyclonal Antibody |
|||
| GR109009 | Genorise Scientific | 50 mg | EUR 398 |
Polyclonal IL-8 Antibody |
|||
| APR00274G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human IL-8 . This antibody is tested and proven to work in the following applications: |
|||
IL-8 Polyclonal Antibody |
|||
| 41063-100ul | SAB | 100ul | EUR 302.4 |
IL-8 Polyclonal Antibody |
|||
| 41063-50ul | SAB | 50ul | EUR 224.4 |
IL-8 Polyclonal Antibody |
|||
| ABP51621-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of IL-8 from Human. This IL-8 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human IL-8 |
|||
IL-8 Polyclonal Antibody |
|||
| ABP51621-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of IL-8 from Human. This IL-8 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human IL-8 |
|||
IL-8 Polyclonal Antibody |
|||
| ABP51621-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of IL-8 from Human. This IL-8 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human IL-8 |
|||
IL-8 Polyclonal Antibody |
|||
| ABP54886-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of IL-8 from Human. This IL-8 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human IL-8 |
|||
IL-8 Polyclonal Antibody |
|||
| ABP54886-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of IL-8 from Human. This IL-8 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human IL-8 |
|||
IL-8 Polyclonal Antibody |
|||
| ABP54886-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of IL-8 from Human. This IL-8 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human IL-8 |
|||
IL-8 Polyclonal Antibody |
|||
| ABP52884-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of IL-8 from Human. This IL-8 antibody is for WB, IF, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human IL-8 |
|||
IL-8 Polyclonal Antibody |
|||
| ABP52884-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of IL-8 from Human. This IL-8 antibody is for WB, IF, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human IL-8 |
|||
IL-8 Polyclonal Antibody |
|||
| ABP52884-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of IL-8 from Human. This IL-8 antibody is for WB, IF, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human IL-8 |
|||